Darden’s David Newkirk, Emory’s Peter Topping,
Stanford’s Sean Bandarkar and SMU’s Frank Lloyd, PH.D.
discuss the value of education.
MPI Research’s Jim Laveglia, Ph.D.,
discusses efficiency in the drug discovery
and development process.
Motorola’s LEAH GABRIEL
discusses the Enterprise Mobility business.
Walt Disney World Swan and Dolphin Resort’s
Peter Kacheris discusses going green
in the hospitality industry.
TCP Reliable’s Maurice Barakat and
DDL’s Pat J. Nolan discuss sustainability in packaging
Frost & Sullivan’s
DR. Sudeep Basu discusses the role of biomarkers.
Rider University’s Tan Miller
discusses frameworks
Shire’s Peter Dibiaso
discusses the improving
public perception of the
pharma industry
Frost & Sullivan’s DR. Sudeep Basu
discusses HPC and grid computing
Lisa Keilty , CMP, Manager, Meeting Development Team, Pfizer Inc., discusses the current responsibilities and challenges of pharmaceutical meeting planners.
For one clinical professional, improving organ transportation leads to a business in saving lives.
“Current trends indicate that the
need for consolidation of data systems
is now a critical and strategic
part of the global growth of any
pharmaceutical company...”
Tsunamic’s
Kevin Van Workum, PH.D.
discusses HPC
Finding the
Opportunity
in Tighter
Drug Safety
Regulations
Imagine you’ve been assigned the task of eradicating
a disease that has plagued millions of
people for millennia and for which there is no
medical cure.